Article
How do I incorporate red cell genotyping to improve chronic transfusion therapy?
Transfusion - 1 Jan 2020
Van Buren Nancy L, Gorlin Jed B, Corby Susan M, Cassidy Sandra, FritchLilla Stephanie, Nelson Stephen C, Westhoff Connie M
Abstract excerpt
BACKGROUND: Children with transfusion dependent anemia, such as sickle cell disease (SCD) and thalassemia, are at an increased risk for developing red blood cell (RBC) alloantibodies due to their lifelong need for transfusion therapy. With the advent of genotyping, extended RBC antigen typing can be incorporated into chronic transfusion therapy programs (CTTPs) to improve patient care and provide antigen matched...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.